Boston University: Clinical Trials

41 trials sponsored by Boston University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

27 completed, 5 terminated, 4 recruiting, 3 active not recruiting. 41 Phase 2, 8 Phase 3, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 241Completed 27, Terminated 5, Recruiting 4, Active not recruiting 3, Unknown 2
Phase 38Completed 4, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Phase 14Completed 3, Active not recruiting 1

Follow Boston University: new trials by email

Trials (filtered) newest first · largest first

All 41 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Role of Vitamin K on Knee Osteoarthritis Outcomes
Vitamin K1 500 µg, K1 1000 µg, Vitamin K2 (MK-7) 300 µg - Osteo Arthritis Knee
Phase 1 / Phase 2Active not recruitingBoston University492025-06-032026-09-21
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Probiotic, Placebo - Microtia, Dysbiosis
Phase 2RecruitingVanderbilt University Medical Center2502023-09-182026-08-27
Confirmation of Diet as a Treatment for Gulf War Illness
Dietary Intervention - Gulf War Syndrome, Gulf War Illness
Phase 2 / Phase 3CompletedAmerican University1112023-03-012026-10-05
Study of Bacopa in Gulf War Illness Patients
BacoMind® (Bacopa monnieri standardized extract), Placebo - Gulf War Illness
Phase 2RecruitingNova Southeastern University1702022-12-012025-07-04
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
Enhanced Usual Care (EUC), Nurse Practitioner Tobacco Treatment Team (NPT3) - Cardiopulmonary Disease, Smoking Cessation
Phase 2RecruitingBaystate Medical Center4242022-11-032026-10-01
5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer
Combination cream of 5-fluorouracil and calcipotriene, 5-fluorouracil cream - Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ
Phase 2 / Phase 3RecruitingBoston University2002022-10-152025-11-28
Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
Delamanid, Levofloxacin, Bedaquiline - Tuberculosis, Multidrug-Resistant
Phase 2Active not recruitingBoston University2712022-06-072026-07-08
Pharmacokinetic Study for IV Allopregnanolone
PK-1 Good Manufacturing Practices (GMP) allopregnanolone (Allo) with Dexolve in 0.9% saline for infusion manufactured by the University of California, Davis, PK-2 GMP allopregnanolone (Allo) with Dexolve in 0.9% saline for infusion manufactured by the University of California, Davis. - Pharmacokinetic Study, Post Traumatic Stress Disorder
Phase 2TerminatedBoston University112022-03-042026-06-02
SEPSIS: L. Plantarum Trial
Synbiotic, Probiotic, Placebo - Microbial Colonization, Tolerance
Phase 2CompletedThe Hospital for Sick Children5192022-01-072023-04-13
Metformin in Alzheimer's Dementia Prevention
Placebo oral tablet, extended release metformin - Mild Cognitive Impairment
Phase 2 / Phase 3Active not recruitingColumbia University3262021-03-222026-08-11
Oral 25-hydroxyvitamin D3 and COVID-19
Oral 25-Hydroxyvitamin D3 - COVID 19
Phase 2 / Phase 3UnknownTehran University of Medical Sciences15002020-04-142020-06-12
Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
Humalog, Novolog, BC222 insulin lispro - Type 1 Diabetes Mellitus
Phase 2 / Phase 3TerminatedMassachusetts General Hospital202019-03-192022-12-09
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18 L-glutamate Derivative BAY94-9392 - Cigarette Smoker, Current Smoker
Phase 2CompletedAndrei Iagaru152019-02-042025-04-09
Intermittent Hypoxia and Caffeine in Infants Born Preterm
Caffeine, Placebos - Intermittent Hypoxia
Phase 2CompletedChildren's National Research Institute1702019-01-182023-09-01
Macitentan in Pulmonary Hypertension of Sickle Cell Disease
macitentan - Pulmonary Hypertension, Sickle Cell Disease
Phase 2TerminatedBoston University42015-07-012020-12-08
Tau Imaging of Chronic Traumatic Encephalopathy
[F18]-T807, [F18]-Florbetapir, MRI/MRS - Chronic Traumatic Encephalopathy
Phase 2CompletedBrigham and Women's Hospital302015-01-012018-05-17
Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB
Levofloxacin, Optimized background regimen (OBR) - Tuberculosis, Multidrug-Resistant
Phase 2CompletedBoston University1112015-01-012023-05-24
Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD)
Auditory-Motor Mapping Training, Speech-Repetition Therapy - Autism
Phase 2 / Phase 3CompletedBeth Israel Deaconess Medical Center142014-11-012020-05-19
Intranasal Insulin: A Novel Treatment for Gulf War Multisymptom Illness
Intranasal Insulin, Placebos - Chronic Multisymptom Illness in Gulf War Veterans
Phase 2UnknownBronx Veterans Medical Research Foundation, Inc1142014-04-012017-10-06
Safety and Effect of Doxycycline in Patients With Amyloidosis
Doxycycline 100 mg po bid x 12 months - Amyloidosis
Phase 2CompletedBoston University252012-07-012017-08-01

Showing 20 of 41. Sign in to see all of them.

Conditions studied

Alcohol Drinking (3)  ·  Alcoholism (3)  ·  beta-Thalassemia (3)  ·  Alcoholic Intoxication (2)  ·  Amyloidosis (2)  ·  Amyloidosis, Familial (2)  ·  Autistic Disorder (2)  ·  Cocaine-Related Disorders (2)  ·  HIV Infections (2)  ·  Neurobehavioral Manifestations (2)  ·  Smoking Cessation (2)  ·  Substance-Related Disorders (2)  ·  Tuberculosis, Multidrug-Resistant (2)  ·  AA amyloidosis (1)  ·  Acquired Immunodeficiency Syndrome (1)

Interventions

2,2-dimethylbutyric acid (2)  ·  Insulin (2)  ·  Lasers, Gas (2)  ·  Levofloxacin (2)  ·  Probiotics (2)  ·  arginine butyrate (2)  ·  4-(3-fluoropropyl)glutamic acid (1)  ·  7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1)  ·  Acupuncture Therapy (1)  ·  Anti-Infective Agents, Local (1)  ·  Beer (1)  ·  Bexarotene (1)  ·  Caffeine (1)  ·  Calcifediol (1)  ·  Celecoxib (1)

Countries

United States (32)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Bangladesh (1)  ·  Iran (1)  ·  Italy (1)  ·  Japan (1)  ·  Lebanon (1)  ·  Peru (1)  ·  Philippines (1)  ·  South Africa (1)  ·  Thailand (1)  ·  Vietnam (1)  ·  Zambia (1)

Top investigators

Adam Lerner, M.D. (1)  ·  Adlette Inati, MD (1)  ·  Amanpreet Cheema, PhD (1)  ·  Ann M Rasmusson, MD (1)  ·  Arash Shirvani, MD, PhD (1)  ·  Bei-Hung Chang, Sc.D. (1)  ·  Bilal Fawaz, MD (1)  ·  Bryan King, MD (1)  ·  Carina Mari Aparici (1)  ·  Carl E. Hunt, M.D. (1)  ·  Charles Horsburgh, MD (1)  ·  Charles R Horsburgh, MD (1)  ·  Clifford Knapp, PhD (1)  ·  Daniel Roth, MD, PhD (1)  ·  Davidson H Hamer, MD (1)

Results publications

PMID 17515522, PMID 19487623, PMID 21134017, PMID 21705396, PMID 21859168, PMID 24061784, PMID 24101698, PMID 24368466, PMID 24445955, PMID 25249577, PMID 25599449, PMID 25646254, PMID 27693439, PMID 27992261, PMID 28558800, PMID 28749480, PMID 28981994, PMID 29178937, PMID 30012767, PMID 30277862, PMID 30373800, PMID 33757717, PMID 33951036, PMID 35256443, PMID 35996282, PMID 37039338, PMID 37203336, PMID 37811711, PMID 39992135, PMID 40064371, PMID 40080768, PMID 41285561, PMID 42066676

NIH funding

P60AA013759 (2), K23AR082938 (1), R01AG062624 (1), R01DC006617 (1), R01HD089289 (1), R01MH122867 (1), R01NS051306 (1), R21AT003377 (1), R21DC006853 (1), R49CE000946 (1), U01AI100805 (1), U01AI152980 (1), U54MH066398 (1)